Research programme: progesterone - Encore Therapeutics

Drug Profile

Research programme: progesterone - Encore Therapeutics

Alternative Names: ETI-411; PE/Progesterone

Latest Information Update: 06 Apr 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Encore Therapeutics
  • Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules; Steroids
  • Mechanism of Action Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • Available For Licensing Yes

Highest Development Phases

  • Research Brain injuries; Stroke

Most Recent Events

  • 06 Apr 2011 Research is ongoing in USA
  • 25 Jun 2008 Early research in Brain injuries in USA (IV)
  • 25 Jun 2008 Early research in Stroke in USA (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top